Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$8.49 - $19.54 $254,700 - $586,200
-30,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.44 - $11.29 $74,400 - $112,899
10,000 Added 50.0%
30,000 $312,000
Q4 2019

Feb 14, 2020

BUY
$7.99 - $37.6 $159,800 - $752,000
20,000 New
20,000 $160,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.12B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Atlas Principals, LLC Portfolio

Follow Atlas Principals, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Principals, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Principals, LLC with notifications on news.